ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Single-use Bioprocessing Probes and Sensors Market 2022 to 2027 - Growth, Trends, Covid-19 Impact, and Forecasts - ResearchAndMarkets.com

PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.
December 19, 2022 GMT

DUBLIN--(BUSINESS WIRE)--Dec 19, 2022--

The “Single-use Bioprocessing Probes and Sensors Market - Growth, Trends, Covid-19 Impact, and Forecasts (2022 - 2027)” report has been added to ResearchAndMarkets.com’s offering.

The single-use bioprocessing probes and sensors market is projected to register a CAGR of 13% during the forecast period.

Companies Mentioned

  • Thermo Fisher Scientific Inc.
  • Sartorius AG
  • Danaher Corporation
  • PreSens Precision Sensing GmbH
  • METTLER TOLEDO
  • Equflow B.V.
  • Parker-Hannifin Corporation
  • Broadley-James Corporation
  • Malema Engineering Corporation
  • Hamilton Company
  • CerCell A/S
  • Emerson Electric Co.

Key Market Trends

The pH sensor segment is expected to account for the major share

The pH sensor segment is expected to account for the major share during the forecast period owing to the highest penetration of the product in terms of usage and availability. The development of disposable pH sensors that combines the reliability and measurement capabilities of conventional sensors along with the ease of use as an integral part of single-use containers is driving the segment growth.

ADVERTISEMENT

In March 2021, Mettler-Toledo International Inc. announced acquisition of PendoTECH, an independent supplier of single-use technology including pH sensors. This acquisition would expand client base for both the companies, thereby driving their business revenue. Such ongoing activities in the space are expected to significantly accelerate the segment growth.

Despite the presence of a high number of disposables pH sensors, this segment continues to witness demand for sensor innovation among biopharmaceutical manufacturers. As a result, market players are undertaking various market measures to address the industry needs.

Furthermore, market players are engaged in the development of systems that advance and compress unit operations, for example, smart consumables with integrated sensors for pH, Dissolved Oxygen (DO), and other parameters. These factors are anticipated to greatly benefit the segment growth in terms of revenue generation in the coming years.

North America is Expected to Hold a Significant Share in the Market and Expected to Maintain its Dominance in the Forecast Period.

The key factor contributing to the dominance of North America is the presence of a substantial number of technology developers including OEMs and independent suppliers in the United States coupled with a high concentration of bioprocessing facilities in the region.

ADVERTISEMENT

The presence of major biomanufacturers such as Thermo Fisher, FUJIFILM Diosynth Biotechnologies U.S.A., Inc., AbbVie, Inc., Novartis AG, and CMC Biologics in the United States that deploys single-use solutions in their biomanufacturing facilities is anticipated to serve as one of the key driving forces of the market in North America. For instance, in March 2021, Thermo Fisher launched 3,000L and 5,000L HyPerforma DynaDrive single-use bioreactors for cell culture production. The DynaDrive 50L and 500L models were launched in 2020 with new features, including improved sensor technology alongside other features.

ADVERTISEMENT

Rising popularity and demand for biotherapeutics that involve the use of bioprocessing instruments further pressure the manufacturers to reduce the timeline of final product launch while maintaining the yield and quality of production. This further spurs the adoption of single-use technology for biomanufacturing of biotherapeutics owing to the cost and time-saving advantages of disposables over conventional bioprocess instruments.

For instance, in December 2021, Fujifilm Diosynth Biotechnologies announced to invest USD 300 million for expansion of its advance therapy and vaccine manufacturing capacity by the addition of a new single-use cGMP production facility in its Texas site.

Key Topics Covered:

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Market Drivers

4.2.1 Commercial Advantages Over Stainless Steel Bioprocessing Products

4.2.2 Rising Investment for Single-use Bioprocessing Facility Expansion

ADVERTISEMENT

4.3 Market Restraints

4.3.1 Environmental and Technical Challenges

4.4 Porter’s Five Force Analysis

5 MARKET SEGMENTATION

5.1 By Type

5.1.1 pH Sensor

5.1.2 Oxygen Sensor

5.1.3 Pressure Sensors

5.1.4 Temperature Sensors

5.1.5 Conductivity Sensors

5.1.6 Flow Meters & Sensors

5.1.7 Others

5.2 By Workflow

5.2.1 Upstream

5.2.2 Downstream

5.3 By End User

5.3.1 Biopharmaceutical Manufacturers

5.3.2 CMOs & CROs

5.3.3 Other End Users

5.4 Geography

6 COMPETITIVE LANDSCAPE

6.1 Company Profiles

6.1.1 Thermo Fisher Scientific Inc.

6.1.2 Sartorius AG

6.1.3 Danaher Corporation

6.1.4 PreSens Precision Sensing GmbH

6.1.5 METTLER TOLEDO

6.1.6 Equflow B.V.

6.1.7 Parker-Hannifin Corporation

6.1.8 Broadley-James Corporation

6.1.9 Malema Engineering Corporation

6.1.10 Hamilton Company

6.1.11 CerCell A/S

6.1.12 Emerson Electric Co.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

For more information about this report visit https://www.researchandmarkets.com/r/zhf6ni

View source version on businesswire.com:https://www.businesswire.com/news/home/20221219005589/en/

ADVERTISEMENT

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH MEDICAL DEVICES

SOURCE: Research and Markets

Copyright Business Wire 2022.

PUB: 12/19/2022 11:03 AM/DISC: 12/19/2022 11:03 AM

http://www.businesswire.com/news/home/20221219005589/en